V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160017429 | 160008666 | 1.63 | 51 | Curative (C) | 2016-12-26 | 2017-01-26 | CAP | 02 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 101753260 |
| 160017434 | 160008667 | 1.6 | 81.4 | Palliative (P) | 2020-04-25 | 2020-05-01 | CARBOPLATIN + PACLITAXEL | null | N | CARBOPLATIN + PACLITAXEL | 100288250 |
| 160017435 | 160008668 | 1.66 | 65 | Neo-adjuvant (N) | 2016-03-28 | 2016-04-13 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100270980 |
| 160017437 | 160008669 | 1.68 | 87.2 | null | null | 2018-08-08 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101512311 |
| 160017442 | 160008670 | 0 | 14.6 | Palliative (P) | 2019-11-28 | 2019-12-12 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100167843 |
| 160017444 | 160008671 | 1.74 | 94.6 | Palliative (P) | 2018-06-09 | 2018-06-23 | IVA | 02 | N | LIPOSOMAL DOXORUBICIN | 100126331 |
| 160017450 | 160008672 | 1.62 | 98.6 | Palliative (P) | 2017-01-11 | 2017-01-25 | Carboplatin AUC 6 - 10 | 99 | N | CARBOPLATIN | 101297822 |
| 160017452 | 160008673 | null | 75.6 | Palliative (P) | null | 2017-06-01 | Doxorubicin 75mg/m2 | N | null | DOXORUBICIN | 101226834 |
| 160017454 | 160008674 | 1.68 | 56.4 | Palliative (P) | 2015-01-26 | 2015-01-29 | GEMCITABINE | 02 | N | BEVACIZUMAB + CARBO + PACLITAXEL | 100695137 |
| 160017457 | 160008675 | 1.71 | 89.7 | Palliative (P) | 2018-11-20 | 2018-11-20 | OSIMERTINIB | 02 | N | GEMCARBO | 100866679 |
| 160017458 | 160008676 | 1.79 | 60 | Palliative (P) | 2017-11-16 | 2017-12-06 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100059797 |
| 160017462 | 160008677 | 1.81 | 94.4 | Palliative (P) | 2019-07-27 | 2019-08-04 | Trial Unspecified | 02 | N | ENZALUTAMIDE | 100297998 |
| 160017463 | 160008678 | 1.74 | 64 | Neo-adjuvant (N) | 2017-11-10 | 2017-11-13 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | CYCLOPHOSPHAMIDE | 100283125 |
| 160017464 | 160008679 | 1.74 | 50 | Palliative (P) | 2017-05-17 | 2017-06-01 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101623145 |
| 160017466 | 160008680 | 1.73 | 66 | Palliative (P) | null | 2016-06-11 | Liposomal Doxorubicin 40mg/m2 | null | N | BEP | 101683920 |
| 160017471 | 160008682 | 1.73 | 66 | Palliative (P) | 2017-08-05 | 2017-08-13 | Paclitaxel 7 day | null | N | ECX | 101392484 |
| 160017473 | 160008683 | 1.69 | 78.7 | Neo-adjuvant (N) | 2018-10-06 | 2018-10-13 | CHLORAMBUCIL + RITUXIMAB | 01 | N | DOXORUBICIN + OLARATUMAB | 101144339 |
| 160017474 | 160008684 | 0 | 68.7 | Palliative (P) | 2016-12-06 | 2016-12-11 | Liposomal Doxorubicin (Caelyx) | 02 | N | DOXORUBICIN + OLARATUMAB | 100998218 |
| 160017476 | 160008685 | 1.63 | 50 | Curative (C) | 2017-11-12 | 2017-11-27 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101680592 |
| 160017478 | 160008686 | 1.82 | 90.3 | Adjuvant (A) | 2020-01-31 | 2020-02-01 | Pemetrexed | 02 | N | CARBOPLATIN + PACLITAXEL | 100961019 |
| 160017480 | 160008687 | 0 | 16 | Curative (C) | null | null | EW EuroEwing 2012 Arm B VDC | 02 | N | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 100968982 |
| 160017487 | 160008688 | 1.56 | 89.2 | Palliative (P) | 2019-10-02 | 2019-10-04 | Carboplatin + Paclitaxel (3 weekly) | null | null | CARBOPLATIN + PACLITAXEL | 100243067 |
| 160017488 | 160008689 | 1.52 | 102.6 | Palliative (P) | 2017-04-13 | 2017-04-17 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101263396 |
| 160017489 | 160008690 | 1.87 | 86.3 | Palliative (P) | 2018-07-04 | 2018-07-04 | Bevacizumab+Carbo+Pacliaxel | 02 | N | CAV | 101800761 |
| 160017490 | 160008691 | 1.83 | 122.6 | Palliative (P) | 2018-11-09 | 2018-12-01 | Doxorubicin + Olaratumab | 02 | N | LIPOSOMAL DAUNORUBICIN | 100770715 |
| 160017493 | 160008692 | 1.75 | 80 | Palliative (P) | 2014-06-25 | 2014-07-14 | Trial Unspecified | 02 | N | DOXORUBICIN + OLARATUMAB | 101576975 |
| 160017494 | 160008693 | 1.7 | 78.9 | Curative (C) | 2016-04-21 | 2016-04-22 | Doxorubicin + Ifosfamide | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101624149 |
| 160017495 | 160008694 | null | 34.1 | Neo-adjuvant (N) | 2014-07-16 | 2014-08-06 | Doxorubicin + Olaratumab | null | N | TRIAL UNSPECIFIED | 100568199 |
| 160017496 | 160008695 | 1.9 | 76 | Palliative (P) | 2019-02-23 | 2019-03-27 | NHL 2003 Gp C COP | null | N | PACLITAXEL | 100936621 |
| 160017497 | 160008696 | 1.67 | 63.1 | Palliative (P) | 2016-12-10 | 2016-12-24 | CARBOPLATIN + PACLITAXEL | N | null | CARBOPLATIN + PACLITAXEL | 101846682 |
| 160017498 | 160008697 | 0 | 12.5 | Curative (C) | 2019-12-03 | 2019-12-07 | EW EuroEwing 2012 Arm A VAI | null | N | DOXORUBICIN + OLARATUMAB | 101052864 |
| 160017499 | 160008698 | 1.58 | 91 | Curative (C) | 2018-06-23 | 2018-07-02 | Bevacizumab 15mg/kg | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100444990 |
| 160017502 | 160008699 | 1.62 | 67.8 | Palliative (P) | 2018-05-02 | 2018-05-06 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101525945 |
| 160017504 | 160008700 | 1.73 | 85.6 | Palliative (P) | 2019-02-08 | 2019-02-11 | OST Euramos 1 Closed Trial - AP | N | N | LIPOSOMAL DOXORUBICIN | 100130568 |
| 160017505 | 160008701 | 1.77 | 96 | null | 2019-01-03 | 2019-01-22 | Liposomal Doxorubicin (Caelyx) | N | N | LIPOSOMAL DOXORUBICIN | 101717240 |
| 160017507 | 160008702 | 1.5 | 79.3 | Palliative (P) | 2018-05-29 | 2018-06-01 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101128029 |
| 160017510 | 160008703 | 1.65 | 82 | Palliative (P) | 2020-01-23 | 2020-01-23 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100415692 |
| 160017511 | 160008704 | 1.59 | 96.55 | Palliative (P) | 2017-01-20 | 2017-01-22 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100050013 |
| 160017514 | 160008705 | 1.69 | 74 | Palliative (P) | 2019-01-15 | 2019-01-26 | ECX | 2 | N | LIPOSOMAL DOXORUBICIN | 101654162 |
| 160017517 | 160008707 | 1.55 | 105 | Palliative (P) | 2014-09-04 | 2016-11-19 | Bevacizumab+Carbo+Pacliaxel | null | N | CISPLATIN + PEMETREXED | 100509910 |
| 160017518 | 160008708 | 1.82 | 82 | null | 2018-08-23 | 2018-08-24 | Cisplatin + Pemetrexed | N | null | CISPLATIN + PEMETREXED | 100235341 |
| 160017521 | 160008709 | 1.81 | 97 | Palliative (P) | 2016-12-29 | 2016-12-29 | Enzalutamide | 01 | N | EW EUROEWING 2012 ARM A VAI | 101289144 |
| 160017523 | 160008710 | 1.72 | 82.2 | Curative (C) | null | 2016-01-27 | Enzalutamide | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101634920 |
| 160017524 | 160008711 | 1.74 | 59.8 | Curative (C) | 2016-04-06 | 2016-04-10 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | PACLITAXEL | 100942716 |
| 160017526 | 160008712 | 1.81 | 70 | Palliative (P) | 2018-01-25 | 2018-01-28 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 100360498 |
| 160017527 | 160008713 | 1.76 | 57.8 | Palliative (P) | 2019-09-25 | 2019-10-16 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100500675 |
| 160017529 | 160008714 | 1.58 | 63.9 | Palliative (P) | 2016-05-18 | 2016-06-06 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101638514 |
| 160017534 | 160008715 | 1.81 | 59.2 | Palliative (P) | 2016-04-15 | 2016-04-15 | Liposomal Doxorubicin (Caelyx) | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101784882 |
| 160017538 | 160008716 | 1.81 | 0 | Palliative (P) | 2017-04-10 | 2017-04-12 | Trial Unspecified | 02 | N | CISPLATIN + PACLITAXEL | 101583613 |
| 160017540 | 160008717 | 1.78 | 98.6 | Curative (C) | 2018-01-26 | 2018-02-09 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100888376 |